Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Carcinoma × Mitomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 2 Urinary Bladder Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Carcinoma 1

Interventions

Pemetrexed 3 Carboplatin 3 durvalumab 2 Cisplatin 2 tremelimumab 1 repotrectinib 1 pralsetinib 1 osimertinib 1 brigatinib 1 atezolizumab 1 Surgical Procedures, Operative 1 Paclitaxel 1 Mitomycin 1 Gemcitabine 1 Crizotinib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02793128 2020-12-22

Olympus

UroGen Pharma Ltd.

Phase 3 Completed

71 enrolled 16 charts 2 FDA

Carcinoma, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡